GL Pharm Tech

GL Pharm Tech EPS

The Earnings per Share (EPS) of GL Pharm Tech (204840.KQ) as of Oct 20, 2026 is 0.37 KRW. In the previous year, Earnings per Share (EPS) was -69.67 KRW — a change of -100.53% (higher).

EPS

0.37KRW

YoY

-100.53%

Last updated:

Earnings per Share (EPS) of GL Pharm Tech is 2025 0.37 KRW. Earnings per Share (EPS) of GL Pharm Tech was 2024 -69.67 KRW. It decreases by -100.53% higher compared to the previous year.

The GL Pharm Tech EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2018
-159.45 KRW
Jan 1, 2019
-164.40 KRW
Jan 1, 2020
-100.05 KRW
Jan 1, 2021
-111.10 KRW
Jan 1, 2022
-23.55 KRW
Jan 1, 2023
-111.73 KRW
Jan 1, 2024
-69.67 KRW
Jan 1, 2025
0.37 KRW
The GL Pharm Tech EPS history
YEAREPSYoY
0.37KRW-100.53%
-69.67KRW-37.64%
-111.73KRW+374.40%
-23.55KRW-78.80%
-111.10KRW+11.05%
-100.05KRW-39.14%
-164.40KRW+3.10%
-159.45KRW+26.26%
-126.29KRW-22.89%
-163.77KRW-32,774.99%
0.50KRW-114.32%
-3.50KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

GL Pharm Tech Stock analysis

What does GL Pharm Tech do? GL Pharm Tech Corp, based in Seongnam, South Korea, operates in the Health Care sector, specializing in pharmaceutical research and development services as well as the manufacturing and sale of pharmaceutical products. Listed on the stock market on 20 November 2014, the company focuses on developing and supplying pharmaceutical solutions within the Korean market. GL Pharm Tech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GL Pharm Tech stock

Earnings per Share (EPS) of GL Pharm Tech is 0.37 KRW in 2025.

Earnings per Share (EPS) of GL Pharm Tech changed from -69.67 KRW to 0.37 KRW, representing a -100.53% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) GL Pharm Tech since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — GL Pharm Tech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — GL Pharm Tech